George Medicines, a new spinout from Australia’s George Institute for Global Health, could offer patients better control of their blood pressure as well as fewer side effects thanks to an ...
GMRx2, George Medicines’ lead pipeline candidate for the treatment of hypertension including initial treatment, is a proprietary single-pill combination of three best-in-class medicines: telmisartan, ...
Combining three proven medications—telmisartan, amlodipine, and indapamide—into a single daily dose, GMRx2 simplifies the treatment process for patients. For years, hypertension care has been ...